NCT02654119 2025-12-12Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After SurgeryUniversity of NebraskaPhase 2 Completed20 enrolled
NCT00006089 2019-07-31Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial CancerNational Cancer Institute (NCI)Phase 2 Completed34 enrolled